You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensin-Converting Enzyme

Showing 1 - 25 of 3,614
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal

Recruiting
  • Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
  • High ACE Activity Fresh Frozen Plasma
  • Normal Saline
  • Saint Louis, Missouri
    Barnes-Jewish Hospital
Oct 24, 2022

Angiotensin Converting Enzyme rs Gene Polymorphism and

Recruiting
  • Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
  • DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
  • Sohag, Egypt
    Sohag university Hospital
Sep 20, 2023

Tranexamic Acid for Angiotensin-converting Enzyme

Completed
  • Angioedema
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    Angiotensin Converting Enzyme in Systemic Lupus Erythematous

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Angiotensin Converting Enzyme test
    • Sohag, Egypt
      Sohag University Hospital
    Aug 24, 2022

    Precision Treatment With Angiotensin Converting Enzyme Inhibitor

    Recruiting
    • Hypertension
    • +2 more
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Sep 7, 2022

      Angiotensin Converting Enzyme Inhibitors and Angiotensin

      Not yet recruiting
      • COVID-19 Pneumonia
      • Covid_19
      • (no location specified)
      Jun 5, 2022

      Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Co-Enzyme Q10
      • (no location specified)
      Jul 4, 2023

      Bradykinin-degradating Enzymes Activities in

      Recruiting
      • Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
      • Assay of Bradykinin-degradating enzymes.
      • Grenoble, France
        Chu Grenoble Alpes
      Jan 14, 2022

      Therapeutic Drug Use for CKD Patients

      Active, not recruiting
      • Chronic Kidney Disease
      • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
      • Jinan, Shandong, China
        Xiao Li，MD
      Apr 18, 2023

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      COVID 19 Trial in Secaucus (HLX71, Placebo)

      Completed
      • COVID 19
      • Secaucus, New Jersey
        Frontage Clinical Services, Inc.
      Mar 20, 2022

      Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)

      Recruiting
      • Surgery
      • +2 more
      • Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
      • +4 more
      • Amsterdam, Netherlands
      • +6 more
      Jan 6, 2022

      Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)

      Recruiting
      • Vascular Access Complication
      • Rawalpindi, Punjab, Pakistan
        Anas Bin Saif
      Nov 22, 2021

      Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary

      Active, not recruiting
      • Pulmonary Arterial Hypertension
        • Jacksonville, Florida
        • +1 more
        Jan 10, 2022

        Covid19 Trial in Vienna (Angiotensin Converting Enzyme 2, Sodium chloride)

        Completed
        • Covid19
        • Angiotensin Converting Enzyme 2
        • Sodium chloride
        • Vienna, Austria
          Medical University of Vienna
        Sep 22, 2022

        Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

        Active, not recruiting
        • Chronic Kidney Disease
        • +3 more
        • Continuation of ACEi and/or ARBs
        • San Francisco, California
          University of California, San Francisco
        Oct 4, 2021

        AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

        Recruiting
        • AML
        • Acute Myeloid Leukemia
        • Charlottesville, Virginia
          University of Virginia
        Jul 2, 2022

        Oral Lesions, COVID-19, Angiotensin-converting Enzyme 2 Trial in Kafr Ash Shaykh (detection of oral lesions)

        Completed
        • Oral Lesions
        • +2 more
        • detection of oral lesions
        • Kafr Ash Shaykh, Kafr El-sheikh, Egypt
          Dalia Rasheed Issa
        Apr 1, 2022

        Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

        Not yet recruiting
        • Diabetic Nephropathy Type 2
        • Empagliflozin 25 MG
        • Enalapril Maleate 20 mg
        • (no location specified)
        May 9, 2022

        Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

        Completed
        Has Results
        • Type 2 Diabetes Mellitus
        • Hypertension
        • Placebo
        • +3 more
        • Nashville, Tennessee
          Vanderbilt University
        Feb 8, 2022

        Oxidative Stress Trial in Guadalajara (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers)

        Completed
        • Oxidative Stress
        • Angiotensin converting enzyme inhibitor
        • Angiotensin Receptor Blockers
        • Guadalajara, Jalisco, Mexico
          Enrique Rojas Campos
        Feb 8, 2022

        Hypertension Trial in London (Preoperative ACEi/ARB management)

        Completed
        • Hypertension
        • Preoperative ACEi/ARB management
        • London, Ontario, Canada
          London Health Sciences Centre
        Oct 21, 2021

        Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

        Recruiting
        • Kidney Disease
        • Chula Vista, California
        • +5 more
        Jan 23, 2023

        Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

        Recruiting
        • Diabetic Kidney Disease
        • Liverpool, New South Wales, Australia
        • +6 more
        May 17, 2022

        Angiotensin-converting Enzyme 2 Expression in Tonsils and

        Withdrawn
        • Adenoidectomy
        • Tonsillectomy
        • Storage of operating waste
        • Créteil, France
        • +8 more
        Jul 5, 2021